Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 186
Filter
1.
BMC Prim Care ; 24(1): 104, 2023 04 20.
Article in English | MEDLINE | ID: mdl-37081385

ABSTRACT

BACKGROUND: Patients with multimorbidity, having two or more chronic diseases, suffer frequently from undiagnosed common mental health problems and are an increasing challenge in primary care. There is a call to improve care delivery to address all these patients' needs at the same time. The aim of this study was to identify general practitioners' experiences of managing patients with multimorbidity and common mental health problems in primary care. METHODS: We conducted five focus group interviews with 28 physicians (3-8 participants in each group) in 5 primary care practices in and outside of Stockholm, Sweden. We used a semi-structured interview guide, and we analysed the data using reflexive thematic analysis. The methodological orientation of the study was inductive, latent constructivism. RESULTS: We generated two themes from the data: Unmet patient needs and fragmented care send patients and physicians off balance and Dancing with the patient individually and together with others leads to confident and satisfied patients and physicians. The two themes are related as general practitioners expressed a need to shift from disease-specific fragmentation to relational continuity, teamwork, and flexibility to meet the needs of patients with multimorbidity and common mental health problems. CONCLUSIONS: These findings can provide guidance in developing future interventions for patients with multimorbidity and common mental health problems in primary care in general, and in Sweden in particular.


Subject(s)
General Practitioners , Humans , Multimorbidity , Mental Health , Attitude of Health Personnel , Qualitative Research
2.
Epidemiol Psychiatr Sci ; 29: e132, 2020 May 28.
Article in English | MEDLINE | ID: mdl-32460950

ABSTRACT

AIMS: Decades of research show that people with schizophrenia have an increased risk of death from cancer; however, the relationship between schizophrenia and cancer incidence remains less clear. This population-based study investigates the incidence of seven common types of cancer among people with a hospital diagnosis of schizophrenia and accounting for the effects of age, sex and calendar time. METHODS: This population-based study used 1990-2013 data from three nationwide Swedish registries to calculate the incidence (in total, by age group and by sex) of any cancer and of lung, oesophageal, pancreatic, stomach, colon, (in men) prostate and (in women) breast cancer in 111 306 people with a hospital diagnosis of schizophrenia. The incidence in people with diagnosed schizophrenia was compared with the incidence in the general population. Risk estimates accounted for the effects of calendar time. RESULTS: In 1 424 829 person-years of follow-up, schizophrenia did not confer an overall higher cancer risk (IRR 1.02, 95% CI 0.91-1.13) but was associated with a higher risk for female breast (IRR 1.19, 95% CI 1.12-1.26), lung (IRR 1.42, 95% CI 1.28-1.58), oesophageal (IRR 1.25, 95% CI 1.07-1.46) and pancreatic (IRR 1.10, 95% CI 1.01-1.21) and a lower risk of prostate (IRR 0.66, 95% CI 0.55-0.79) cancer. Some age- and sex-specific differences in risk were observed. CONCLUSIONS: People with schizophrenia do not have a higher overall incidence of cancer than people in the general population. However, there are significant differences in the risk of specific cancer types overall and by sex calling for efforts to develop disease-specific prevention programmes. In people with schizophrenia, higher risk generally occurs in those <75 years.


Subject(s)
Neoplasms/epidemiology , Registries/statistics & numerical data , Schizophrenia/epidemiology , Adult , Age Distribution , Aged , Cohort Studies , Female , Humans , Incidence , Male , Middle Aged , Population Surveillance , Risk Factors , Schizophrenia/diagnosis , Sex Distribution , Sweden/epidemiology
3.
BMC Fam Pract ; 20(1): 108, 2019 07 27.
Article in English | MEDLINE | ID: mdl-31351444

ABSTRACT

BACKGROUND: The collaborative care model with a care manager has previously generated beneficial results for patients with depression in terms of decreased burden of depression symptoms. A care manager function has been tested in Sweden in the PRIM-CARE RCT with successful results. The aim of the present study was to evaluate the process of implementing care managers in collaborative care for patients with depression in Swedish primary health care in the PRIM-CARE RCT. METHODS: The study followed UK Medical Research Council guidance for process evaluation. Field notes from the implementation of the PRIM - CARE RCT were used, as well as data collected from five focus group discussions with General Practitioners (n = 29) and three focus group discussions with care managers (n = 11). Data were analysed with content analysis. RESULTS: Training sessions, careful preparation and extensive initial support to the care manager and staff at the Primary Care Centres were important ingredients in the implementation. The close access to facilitators, the recurrent peer support meetings, and the weekly newsletter strengthened the care manager function. CONCLUSIONS: A complex intervention adapted to the Swedish primary care context focusing on a care manager function for patients with depression could be performed through a stepwise implementation process. Financial support from the health care regions included in the study helped to reduce the impact of identified barriers. This process evaluation has revealed new and important knowledge for primary care development concerning infrastructure and organization building, knowledge sharing, and facilitating factors and barriers. TRIAL REGISTRATION: NCT02378272 Care Manager - Coordinating Care for Person Centered Management of Depression in Primary Care (PRIM - CARE). Registered March 4 2015. Retrospectively registered.


Subject(s)
Case Managers , Depression/therapy , General Practitioners , Primary Health Care/standards , Process Assessment, Health Care , Quality Improvement , Focus Groups , Humans , Sweden
4.
Transfus Med ; 29(3): 202-208, 2019 Jun.
Article in English | MEDLINE | ID: mdl-29873420

ABSTRACT

OBJECTIVES: To determine the genetic background underlying the Pk phenotype in two Thai sisters suffering from multiple spontaneous abortions. BACKGROUND: The P antigen is carried by globoside, an abundant glycosphingolipid in the red blood cell (RBC) membrane. Inactivating mutations in the 3-ß-N-acetylgalactosaminyltransferase gene (B3GALNT1) give rise to the rare Pk phenotype, which lack the P and PX2 antigens. Consequently, naturally occurring anti-P may cause recurrent miscarriages following the cytotoxic attack of the globoside-rich fetal portion of the placenta. METHODS/MATERIALS: P/P1/PX2/Pk antigens on RBCs and their corresponding antibodies were detected by haemagglutination and flow cytometry. The B3GALNT1 coding region was sequenced, and an allele-specific polymerase chain reaction (PCR) was developed. RESULTS: The two sisters had suffered 8 and 11 miscarriages, most of which occurred in the first trimester. Anti-P and anti-PX2 were identified in their plasmas, and the RBCs typed as P-PX2-Pk +, i.e. had the Pk phenotype. Sequencing revealed homozygosity for a nonsense mutation, c.420T>G, in B3GALNT1. This substitution introduces a premature stop codon, p.Tyr140Ter, which is predicted to abolish enzymatic activity. Screening of 384 Thai donors indicated an allele frequency of 0·13%. CONCLUSION: We describe a novel nonsense mutation (c.420T>G) in B3GALNT1 (GLOB*01N·13), which was added to the 12 alleles already known in the GLOB system.


Subject(s)
Abortion, Spontaneous/genetics , Blood Group Antigens/genetics , Codon, Nonsense , Genetic Loci , N-Acetylgalactosaminyltransferases/genetics , Adult , Female , Humans , Pregnancy
5.
Work ; 60(1): 63-73, 2018.
Article in English | MEDLINE | ID: mdl-29733038

ABSTRACT

BACKGROUND: Depression reduces individuals' function and work ability and is associated with both frequent and long-term sickness absence. OBJECTIVE: Investigate if monitoring of depression course using a self-assessment instrument in recurrent general practitioner (GP) consultations leads to improved work ability, decreased job strain, and quality of life among primary care patients. METHODS: Primary care patients n = 183, who worked. In addition to regular treatment (control group), intervention patients received evaluation and monitoring and used the MADRS-S depression scale during GP visit at baseline and at visits 4, 8, and 12 weeks. Work ability, quality of life and job strain were outcome measures. RESULTS: Depression symptoms decreased in all patients. Significantly steeper increase of WAI at 3 months in the intervention group. Social support was perceived high in a significantly higher frequency in intervention group compared to control group. CONCLUSIONS: Monitoring of depression course using a self-assessment instrument in recurrent GP consultations seems to lead to improved self-assessed work ability and increased high social support, but not to reduced job strain or increased quality of life compared to TAU. Future studies concerning rehabilitative efforts that seek to influence work ability probably also should include more active interventions at the workplace.


Subject(s)
Depression/complications , Job Satisfaction , Self-Assessment , Adult , Depression/psychology , Female , General Practitioners/trends , Humans , Male , Middle Aged , Primary Health Care/methods , Psychometrics/instrumentation , Psychometrics/methods , Quality of Life/psychology , Referral and Consultation/standards , Sick Leave , Stress, Psychological/complications , Stress, Psychological/etiology , Stress, Psychological/psychology , Surveys and Questionnaires , Sweden
6.
Epidemiol Psychiatr Sci ; 27(5): 519-527, 2018 10.
Article in English | MEDLINE | ID: mdl-28580898

ABSTRACT

AimsPeople who have schizophrenia die earlier from somatic diseases than do people in the general population, but information about cardiovascular deaths in people who have schizophrenia is limited. We analysed mortality in all age groups of people with schizophrenia by specific cardiovascular diseases (CVDs), focusing on five CVD diagnoses: coronary heart disease, acute myocardial infarction, cerebrovascular disease, heart failure and cardiac arrhythmias. We also compared hospital admissions for CVDs in people who had schizophrenia with hospital admissions for CVDs in the general population. METHODS: This national register study of 10 631 817 people in Sweden included 46 911 people who were admitted to the hospital for schizophrenia between 1 January 1987 and 31 December 2010. Information from national registers was used to identify people who had schizophrenia and obtain data about mortality, causes of death, medical diagnoses and hospitalisations. RESULTS: CVDs were the leading cause of death in people who had schizophrenia (5245 deaths), and CVDs caused more excess deaths than suicide. The mean age of CVD death was 10 years lower for people who had schizophrenia (70.5 years) than the general population (80.7 years). The mortality rate ratio (MRR) for CVDs in all people who had schizophrenia was 2.80 (95% confidence interval (CI) 2.73-2.88). In people aged 15-59 years who had schizophrenia, the MRR for CVDs was 6.16 (95% CI 5.79-6.54). In all people who had schizophrenia, the MRR for coronary heart disease was 2.83 (95% CI 2.73-2.94); acute myocardial infarction, 2.62 (95% CI 2.49-2.75); cerebrovascular disease, 2.4 (95% CI 2.25-2.55); heart failure, 3.25 (95% CI 2.94-3.6); and cardiac arrhythmias, 2.06 (95% CI 1.75-2.43). Hospital admissions for coronary heart disease were less frequent in people who had schizophrenia than in the general population (admission rate ratio, 0.88 (95% CI 0.83-0.94). In all age groups, survival after hospital admission for CVD was lower in people who had schizophrenia than in the general population. CONCLUSIONS: People who had schizophrenia died 10 years earlier from CVDs than did people in the general population. For all five CVD diagnoses, mortality risk was higher for those with schizophrenia than those in the general population. Survival after hospitalisation for CVDs in people who had schizophrenia was comparable with that of people in the general population who were several decades older.


Subject(s)
Cardiovascular Diseases/mortality , Schizophrenia/epidemiology , Adult , Age Factors , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Registries , Schizophrenic Psychology , Sweden/epidemiology
7.
BMC Fam Pract ; 18(1): 6, 2017 01 19.
Article in English | MEDLINE | ID: mdl-28103816

ABSTRACT

BACKGROUND: Little information is available about whether the use of self-assessment instruments in primary care affects depression course and outcome. The purpose was to evaluate whether using a depression self-rating scale in recurrent person-centred GP consultations affected depression severity, quality of life, medication use, and sick leave frequency. METHODS: Patients in the intervention group met their GP regularly at least 4 times during the 3 months intervention. In addition to treatment as usual (TAU), patients completed a self-assessment instrument (Montgomery-Asberg Depression Rating Scale) on each occasion, and then GPs used the completed instrument as the basis for a person-centred discussion of changes in depression symptoms. The control group received TAU. Frequency of visits in the TAU arm was the result of the GPs' and patients' joint assessments of care need in each case. Depression severity was measured with Beck Depression Inventory-II (BDI-II), quality of life with EQ-5D, and psychological well-being with the General Health Questionnaire-12 (GHQ-12). Data on sick leave, antidepressant and sedatives use, and care contacts were collected from electronic patient records. All variables were measured at baseline and 3, 6, and 12 months. Mean intra-individual changes were compared between the intervention and TAU group. RESULTS: There were no significant differences between the intervention and control group in depression severity reduction or remission rate, change in quality of life, psychological well-being, sedative prescriptions, or sick leave during the whole 12-month follow-up. However, significantly more patients in the intervention group continued antidepressants until the 6 month follow-up (86/125 vs 78/133, p < 0.05). CONCLUSIONS: When GPs used a depression self-rating scale in recurrent consultations, patients more often continued antidepressant medication according to guidelines, compared to TAU patients. However, reduction of depressive symptoms, remission rate, quality of life, psychological well-being, sedative use, sick leave, and health care use 4-12 months was not significantly different from the TAU group. These findings suggest that frequent use of depression rating scales in person-centred primary care consultations has no further additional effect on patients' depression or well-being, sick leave, or health care use. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT01402206 . Registered June 27 2011(retrospectively registered).


Subject(s)
Antidepressive Agents/therapeutic use , Depressive Disorder/therapy , General Practice , Primary Health Care , Quality of Life , Self Report , Sick Leave , Adult , Depressive Disorder/psychology , Disease Management , Female , Humans , Male , Middle Aged , Psychiatric Status Rating Scales , Referral and Consultation , Severity of Illness Index
8.
Acta Psychiatr Scand ; 131(4): 297-306, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25243359

ABSTRACT

OBJECTIVE: To analyse mortality and life expectancy in people with alcohol use disorder in Denmark, Finland and Sweden. METHOD: A population-based register study including all patients admitted to hospital diagnosed with alcohol use disorder (1,158,486 person-years) from 1987 to 2006 in Denmark, Finland and Sweden. RESULTS: Life expectancy was 24-28 years shorter in people with alcohol use disorder than in the general population. From 1987 to 2006, the difference in life expectancy between patients with alcohol use disorder and the general population increased in men (Denmark, 1.8 years; Finland, 2.6 years; Sweden, 1.0 years); in women, the difference in life expectancy increased in Denmark (0.3 years) but decreased in Finland (-0.8 years) and Sweden (-1.8 years). People with alcohol use disorder had higher mortality from all causes of death (mortality rate ratio, 3.0-5.2), all diseases and medical conditions (2.3-4.8), and suicide (9.3-35.9). CONCLUSION: People hospitalized with alcohol use disorder have an average life expectancy of 47-53 years (men) and 50-58 years (women) and die 24-28 years earlier than people in the general population.


Subject(s)
Alcoholism/mortality , Life Expectancy , Adolescent , Adult , Aged , Aged, 80 and over , Denmark/epidemiology , Female , Finland/epidemiology , Hospitalization , Humans , Male , Middle Aged , Sweden/epidemiology , Young Adult
9.
J Periodontal Res ; 50(1): 80-8, 2015 Feb.
Article in English | MEDLINE | ID: mdl-24697598

ABSTRACT

BACKGROUND AND OBJECTIVE: High levels of the antimicrobial peptide, LL-37, are detected in gingival crevicular fluid from patients with chronic periodontitis. LL-37 not only shows antimicrobial activity but also affects host-cell viability. The objective of the present study was to identify endogenous mechanisms that antagonize the detrimental effects of LL-37 on osteoblast viability, focusing on the human peptide p33 expressed on the surface of various cell types. MATERIAL AND METHODS: Human osteoblast-like MG63 cells and human hFOB1.19 osteoblasts were treated with or without LL-37 in the presence or absence of p33. Recombinant human p33 was expressed in an Escherichia coli expression system. Lactate dehydrogenase (LDH) was assessed using an enzymatic spectrophotometric assay. DNA synthesis was determined by measuring [(3) H]-thymidine incorporation. Cell number was assessed by counting cells in a Bürker chamber. Intracellular Ca(2+) was monitored by recording Fluo 4-AM fluorescence using a laser scanning confocal microscope. Cellular expression of p33 was determined by western blotting. RESULTS: LL-37 caused a concentration-dependent release of LDH from human osteoblasts, showing a half-maximal response value (EC50 ) of 4 µm and a rapid and sustained rise in the intracellular Ca(2+) concentration of osteoblasts, suggesting that LL-37 forms pores in the cell membrane. p33 (10 µm) inhibited the LL-37-induced LDH release and LL-37-evoked rise in intracellular Ca(2+) concentration, suggesting that p33 prevents LL-37-induced permeabilization of the cell membrane. Moreover, p33 blocked LL-37-induced attenuation of osteoblast numbers. Also, mucin antagonized, at concentrations representative for nonstimulated whole saliva, LL-37-evoked LDH release, whilst cationic endogenous polyamines had no impact on LL-37-induced LDH release from osteoblasts. CONCLUSIONS: The endogenous peptide p33 prevents LL-37-induced reduction of human osteoblast viability. Importantly, this mechanism may protect the osteoblasts from LL-37-induced cell damage in patients suffering from chronic periodontitis associated with high levels of LL-37 locally.


Subject(s)
Antimicrobial Cationic Peptides/antagonists & inhibitors , Complement C1q/pharmacology , Membrane Glycoproteins/pharmacology , Osteoblasts/drug effects , Antimicrobial Cationic Peptides/pharmacology , Calcium/analysis , Carrier Proteins/pharmacology , Cell Count , Cell Line , Cell Membrane/drug effects , Cell Shape/drug effects , Cell Survival/drug effects , DNA/biosynthesis , DNA/drug effects , Humans , L-Lactate Dehydrogenase/analysis , L-Lactate Dehydrogenase/antagonists & inhibitors , Mitochondrial Proteins/pharmacology , Mucins/pharmacology , Receptors, Complement , Cathelicidins
10.
Immunohematology ; 29(1): 19-24, 2013.
Article in English | MEDLINE | ID: mdl-24046919

ABSTRACT

The P blood group antigen of the GLOB system is a glycolipid structure, also known as globoside, on the red blood cells (RBCs) of almost all individuals worldwide. The P antigen is intimately related to the Pk and NOR antigens discussed in the review about the P1PK blood group system. Naturally occurring anti-P is present in the serum of individuals with the rare globoside-deficient phenotypes p, P1k, and P2k and has been implicated in hemolytic transfusion reactions as well as unfavorable outcomes of pregnancy. The molecular genetic basis of globoside deficiency is absence of functional P synthase as a result of mutations at the B3GALNT1 locus. Other related glycolipid structures, the LKE and PX2 antigens, remain in the GLOB blood group collection pending further evidence about the genes and gene products responsible for their synthesis.


Subject(s)
Erythrocytes/chemistry , Erythrocytes/immunology , P Blood-Group System/chemistry , P Blood-Group System/immunology , Animals , Humans , Molecular Diagnostic Techniques
11.
Immunohematology ; 29(1): 25-33, 2013.
Article in English | MEDLINE | ID: mdl-24046920

ABSTRACT

The antigens in the P1PK blood group system are carried on glycosphingolipids. The system currently includes three different antigens, P1, Pk, and NOR. The P1 antigen was disovered in 1927 by Landsteiner and Levine, and Pk and NOR were described in 1951 and 1982, respectively. As in the ABO system, naturally occurring antibodies of the immunoglobulin (Ig) M or IgG class, against the missing carbohydrate structures, can be present in the sera of people lacking the corresponding antigen. Anti-P1 is generally a weak and cold-reactive antibody not implicated in hemolytic transfusion reaction (HTR) or hemolytic disease of the fetus and newborn while Pk antibodies can cause HTR, and anti-NOR is regarded as a polyagglutinin. A higher frequency of miscarriage is seen in women with the rare phenotypes p, P1k, and P2k. Furthermore, the Pk and P1 antigens have wide tissue distributions and can act as host receptors for various pathogens and toxins. Why p individuals lack not only Pk and P expression but also P1 has been a longstanding enigma. Recently, it was shown that the same A4GALT-encoded galactosyltransferase synthesizes both the P1 and Pk antigens and that a polymorphism in a new exon in this gene predicts the P1 and P2 phenotypes.


Subject(s)
Globosides/immunology , P Blood-Group System/immunology , Humans
12.
Clin Genet ; 82(2): 140-6, 2012 Aug.
Article in English | MEDLINE | ID: mdl-21815888

ABSTRACT

Microcephalic osteodysplastic primordial dwarfism type I (MOPD I) is a rare autosomal recessive developmental disorder characterized by extreme intrauterine growth retardation, severe microcephaly, central nervous system abnormalities, dysmorphic facial features, skin abnormalities, skeletal changes, limb deformations, and early death. Recently, mutations in the RNU4ATAC gene, which encodes U4atac, a small nuclear RNA that is a crucial component of the minor spliceosome, were found to cause MOPD I. MOPD I is the first disease known to be associated with a defect in small nuclear RNAs. We describe here the clinical and molecular data for 17 cases of MOPD I, including 15 previously unreported cases, all carrying biallelic mutations in the RNU4ATAC gene.


Subject(s)
Alleles , Dwarfism/genetics , Fetal Growth Retardation/genetics , Microcephaly/genetics , Mutation , Osteochondrodysplasias/genetics , RNA, Small Nuclear/genetics , Brain/pathology , Dwarfism/diagnosis , Facies , Female , Fetal Growth Retardation/diagnosis , Humans , Infant , Life Expectancy , Magnetic Resonance Imaging , Male , Microcephaly/diagnosis , Osteochondrodysplasias/diagnosis , Phenotype
13.
Eur Psychiatry ; 21(5): 307-14, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16675206

ABSTRACT

This study analysed the association between country of birth and psychotic, affective, and neurotic disorders in seven immigrant categories, after adjustment for demographic and socioeconomic factors. A 2-year national cohort study of 4.5 million individuals in the age group 25-64 years was performed. Swedish national registers including individual demographic and socioeconomic data were linked to the hospital discharge register. Cox regression was used in the analysis. Several groups of immigrants, both men and women, had risks of hospital admission for psychotic, affective, or neurotic disorders compared to the Swedish-born reference group. The impact of demographic and socioeconomic factors on these risks seemed to be larger for men than for women. For foreign-born men, several of the risks no longer remained significant after adjustment for income and marital status. In contrast, most of the risks for foreign-born women remained significant after adjustment for income and marital status. Low income and being single were associated with an increased risk of psychiatric hospital admission. These results represent important knowledge for clinicians and public health planners who are involved in treatment and prevention of mental disorders among certain groups of immigrants, and among low income men and women irrespective of immigrant status.


Subject(s)
Cross-Cultural Comparison , Emigration and Immigration/statistics & numerical data , Ethnicity/statistics & numerical data , Mental Disorders/ethnology , Patient Admission/statistics & numerical data , Adult , Cohort Studies , Ethnicity/psychology , Female , Humans , Male , Mental Disorders/epidemiology , Mental Disorders/psychology , Middle Aged , Mood Disorders/ethnology , Mood Disorders/psychology , Neurotic Disorders/epidemiology , Neurotic Disorders/etiology , Neurotic Disorders/parasitology , Psychotic Disorders/epidemiology , Psychotic Disorders/ethnology , Psychotic Disorders/psychology , Risk , Sex Factors , Socioeconomic Factors , United Kingdom
14.
J Med Genet ; 41(2): 81-91, 2004 Feb.
Article in English | MEDLINE | ID: mdl-14757853

ABSTRACT

BACKGROUND: There have been many papers on the diagnostic criteria for specific hereditary cancer susceptibility syndromes and the likelihood that an individual has a germline mutation in one of the various cancer susceptibility genes. To assist health care professionals in deciding when a cancer genetics consultation is appropriate, available reports were critically reviewed in order to develop a single set of risk assessment criteria. METHODS: The criteria were based on a comprehensive review of publications describing diagnostic criteria for hereditary cancer syndromes and risk to first degree relatives of cancer patients. Priority was given to diagnostic criteria from consensus statements (for example, those from the National Comprehensive Cancer Network). Expert opinion from study personnel was then used to adopt a single set of criteria from other publications whenever guidelines differed. RESULTS: Based on family history, a set of criteria was developed to identify patients at risk for a hereditary cancer susceptibility syndrome, patients with moderate risk who might benefit from increased cancer surveillance, and patients who are at average risk. The criteria were applied to 4360 individuals who provided their cancer family history between July 1999 and April 2002, using a touch screen computer system in the lobby of a comprehensive cancer centre. They categorised an acceptable number of users into each risk level: 14.9% high risk, 13.7% moderate risk, and 59.6% average risk; 11.8% provided insufficient information for risk assessment. CONCLUSIONS: These criteria should improve ease of referral and promote consistency across centres when evaluating patients for referral to cancer genetics specialists.


Subject(s)
Genetic Counseling/statistics & numerical data , Genetic Predisposition to Disease/genetics , Neoplasms/genetics , Referral and Consultation/statistics & numerical data , Female , Genetic Predisposition to Disease/epidemiology , Humans , Male , Neoplasms/epidemiology , Risk Assessment
15.
Acta Neurochir Suppl ; 86: 313-9, 2003.
Article in English | MEDLINE | ID: mdl-14753460

ABSTRACT

Role of carbon monoxide (CO) in hyperthermic brain injury induced brain pathology was examined in a rat model using immunohistochemistry of the hemeoxygenase-2 (HO-2) enzyme. Exposure of rats to 4 h heat stress at 38 degrees C resulted in profound hyperthermia, breakdown of the blood-brain barrier (BBB), brain edema formation, cell damage and expression of HO-2 in several brain regions. Pretreatment with potent antioxidant compounds EGB-761 and BN-52021 markedly reduced the HO-2 expression, BBB breakdown, brain edema formation and cell damage without attenuating the hyperthermic response. This effect was most marked in animals treated with EGB-761. These observations suggest that upregulation of HO-2 representing generation of CO plays important roles in hyperthermic brain injury, and oxidative stress seems to be one of the most important signals in inducing HO-2 expression in hyperthermia, not reported earlier.


Subject(s)
Antioxidants/pharmacology , Brain Edema/prevention & control , Brain Injuries/complications , Diterpenes/pharmacology , Fever/complications , Heme Oxygenase (Decyclizing)/antagonists & inhibitors , Lactones/pharmacology , Plant Extracts/pharmacology , Animals , Blood-Brain Barrier/drug effects , Brain Edema/etiology , Brain Injuries/etiology , Capillary Permeability/drug effects , Ginkgo biloba , Ginkgolides , Hot Temperature , Male , Rats , Rats, Sprague-Dawley , Stress, Physiological/etiology , Stress, Physiological/pathology , Stress, Physiological/physiopathology
16.
Acta Neurochir Suppl ; 86: 389-94, 2003.
Article in English | MEDLINE | ID: mdl-14753474

ABSTRACT

The possibility that the upregulation of hemeoxygenase (HO) enzyme responsible for carbon monoxide (CO) formation in the spinal cord following trauma is involved in edema formation and cell damage was examined in a rat model. A focal trauma to the rat spinal cord by making an incision into the right dorsal horn of the T10-11 segment resulted in profound upregulation of HO-2 (the constitutive isoform of the enzyme) expression in the T9 and T12 segments 5 h after injury. In these segments a marked increase in edema formation, nerve cell damage, and expression of heat shock protein (HSP 72) were observed. Pretreatment with p-chlorophenylalanine (p-CPA, a serotonin synthesis inhibitor) significantly attenuated the trauma induced edema formation, cell injury, and HSP expression. Upregulation of HO-2 in p-CPA treated traumatised rats was considerably reduced. These observations suggest that (i) spinal cord injury has the capacity to induce an upregulation of HO-2 and HSP expression, (ii) abnormal production of CO as reflected by HO-2 expression is injurious to the cord, and (iii) that endogenous serotonin is involved in HO-2 expression in the cord.


Subject(s)
Edema/prevention & control , Fenclonine/pharmacology , Heme Oxygenase (Decyclizing)/antagonists & inhibitors , Serotonin Antagonists/pharmacology , Serotonin/metabolism , Spinal Cord Injuries/complications , Animals , HSP72 Heat-Shock Proteins , Heat-Shock Proteins/metabolism , Immunohistochemistry/methods , Male , Rats , Rats, Sprague-Dawley , Spinal Cord Injuries/pathology , Staining and Labeling , Up-Regulation/drug effects
17.
Acta Neurochir Suppl ; 86: 399-405, 2003.
Article in English | MEDLINE | ID: mdl-14753476

ABSTRACT

The possibility that five new low molecular weight compounds with varying affinity and selectivity to the melanocortin receptors will exert neuroprotective effects in the spinal cord injury (SCI) induced edema formation and cell damage was examined in a rat model. A focal trauma of the rat spinal cord made by an incision into the right dorsal horn (T10-11) resulted in profound edema formation, leakage of Evans blue albumin and cell injury of the T9 segment at 5 h. Topical application of the Melacure compound ME10501 in high doses (10 microg in 10 microl) given 5 min after SCI resulted in most significant neuroprotection of the T9 segment of the cord compared to other compounds. Thus, marked reduction in water content, leakage of Evans blue albumin, and cell injury were observed in ME10501 treated traumatised rats. These observations suggest that the non-peptide compound ME10501 with affinity to the melanocortin receptor MC4 is capable to induce neuroprotection in the spinal cord following trauma not reported earlier.


Subject(s)
Neuroprotective Agents/pharmacology , Receptors, Melanocortin/metabolism , Spinal Cord Injuries/pathology , Animals , Binding, Competitive , Body Water/metabolism , Capillary Permeability/drug effects , Edema/etiology , Male , Molecular Weight , Rats , Rats, Sprague-Dawley , Spinal Cord/blood supply , Spinal Cord/drug effects , Spinal Cord/pathology , Spinal Cord/physiopathology , Spinal Cord Diseases/etiology , Spinal Cord Injuries/complications
18.
Acta Neurochir Suppl ; 86: 407-13, 2003.
Article in English | MEDLINE | ID: mdl-14753477

ABSTRACT

The possibility that antiserum to tumour necrosis factor-alpha (TNF-alpha) is neuroprotective in spinal cord injury (SCI) was examined in a rat model. SCI was produced by making an incision into the right dorsal horn at the T10-11 segments. Top TNF-alpha antiserum at three concentrations (1:10; 1:50 and 1:100) given 30 min before or 2 min, 5 min or 10 min after trauma resulted in marked reduction in visible swelling, edema formation, and leakage of radiolabelled iodine tracer within the T9 and T12 segments at 5 h in a dose dependent manner. This neuroprotective effect was most pronounced when the antiserum at the highest dose level (1:10) was applied 10 min after SCI. The TNF-alpha antiserum also reduced the SCI induced upregulation of neuronal nitric oxide synthase (nNOS) immunoreactivity in a concentration dependent manner. Taken together, these results suggest that local application of TNF-alpha antiserum is neuroprotective in SCI and that this effect is mediated through NOS regulation.


Subject(s)
Edema/prevention & control , Immune Sera/administration & dosage , Spinal Cord Diseases/prevention & control , Spinal Cord Injuries/physiopathology , Tumor Necrosis Factor-alpha/immunology , Administration, Topical , Animals , Capillary Permeability/drug effects , Edema/etiology , Immunohistochemistry , Male , Nitric Oxide Synthase/metabolism , Rats , Rats, Sprague-Dawley , Spinal Cord/blood supply , Spinal Cord Diseases/etiology , Spinal Cord Injuries/complications , Spinal Cord Injuries/pathology
19.
Acta Neurochir Suppl ; 86: 425-32, 2003.
Article in English | MEDLINE | ID: mdl-14753480

ABSTRACT

The influence of the potent L-type Ca[2+] channel antagonist Nimodipine on spinal cord evoked potentials (SCEP) and axonal injury following trauma to the spinal cord was examined in a rat model. Spinal cord injury (SCI) was produced by an incision into the right dorsal horn of the T10-11 segments under urethane anaesthesia (1.5 g/kg, i.p.). SCEPs were recorded by epidural electrodes placed over the T9 (rostral) and T12 (caudal) segments after stimulation of the right tibial and sural nerves. SCI induced a pronounced decrease of the SCEP negative amplitude in the rostral (T9) recordings immediately after trauma. Axonal injury seen as degradation of myelin basic protein (MBP) immunostaining and myelin vesiculation at the ultrastructural level was most pronounced at 5 h. Continuous administration of Nimodipine (2 microg/kg/min, i.v.) from 30 min prior to injury until sacrifice markedly attenuated the changes in SCEP amplitude and latency. Axonal damage, loss of MBP, and myelin vesiculation were much less evident in the nimodipine treated traumatised rats. These observations suggest that Ca[2+] channels play an important role in the trauma induced alterations in SCEP and axonal injury, and indicate a therapeutic value of Ca[2+] blockers in SCI.


Subject(s)
Calcium Channel Blockers/pharmacology , Calcium Channels, L-Type/drug effects , Diffuse Axonal Injury/etiology , Neural Conduction/drug effects , Nimodipine/pharmacology , Spinal Cord Injuries/complications , Spinal Cord Injuries/physiopathology , Animals , Diffuse Axonal Injury/pathology , Edema/prevention & control , Evoked Potentials/drug effects , Male , Myelin Sheath/drug effects , Myelin Sheath/ultrastructure , Rats , Rats, Sprague-Dawley , Reaction Time/drug effects , Regional Blood Flow/drug effects , Spinal Cord/blood supply , Spinal Cord/pathology , Spinal Cord/physiopathology , Spinal Cord Diseases/prevention & control , Spinal Cord Injuries/pathology
20.
Comb Chem High Throughput Screen ; 5(7): 565-70, 2002 Nov.
Article in English | MEDLINE | ID: mdl-12470269

ABSTRACT

A simple and fast one-pot method using microwave irradiation for the synthesis of a number of small libraries of diverse heterocycles is described in this paper. The two-step one-pot method includes the formation of alkylaminopropenones or alkylaminopropenoates in 5 min at 180 degrees C and a subsequent treatment with dinucleophiles for 3 to 5 min at 150 degrees C to 180 degrees C to form a variety of biologically interesting heterocycles in a cascade-type reaction. The combination of combinatorial chemistry and microwave-assisted synthesis was found to be very efficient.


Subject(s)
Combinatorial Chemistry Techniques , Heterocyclic Compounds/chemical synthesis , Microwaves , Amines/chemical synthesis , Molecular Structure
SELECTION OF CITATIONS
SEARCH DETAIL
...